[Objective criteria for assessing benefits of therapy in COPD - ATS/ERS guidelines 2007].
Cuvelier
A
A
Service de Pneumologie et Unité de Soins Intensifs Respiratoires, CHU de Rouen et UPRES EA 3830 (IFR MP23), Institut Hospitalo-Universitaire de Recherche Biomédicale, Université de Rouen, 76031 Rouen Cedex, France. antoine.cuvelier@chu-rouen.fr
Roche
N
N
D015415:Biomarkers / Q000032:analysis; D018849:Controlled Clinical Trials as Topic; D006801:Humans; D017410:Practice Guidelines as Topic; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D012129:Respiratory Function Tests; D019141:Respiratory System Agents / Q000627:therapeutic use; D016896:Treatment Outcome
D015415:Biomarkers; D019141:Respiratory System Agents